• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多血管病变的经皮冠状动脉介入治疗。

Percutaneous Coronary Intervention in Multi-Vessel Disease.

机构信息

London Northwest University Hospital, Watford Road, Harrow HA1 3UJ, London, UK.

National Heart and Lung Institute, Imperial College London, UK; Imperial College Healthcare NHS Trust, 72 Du cane Road, London W12 0HS, UK.

出版信息

Cardiovasc Revasc Med. 2022 Nov;44:80-91. doi: 10.1016/j.carrev.2022.06.254. Epub 2022 Jun 24.

DOI:10.1016/j.carrev.2022.06.254
PMID:35817686
Abstract

Coronary disease carries significant morbidity and mortality globally. The pandemic of obesity and diabetes combined with an aging population have resulted in a significant proportion of patients with multivessel coronary disease, the management of which poses significant challenges. A number of advancements in coronary intervention have emerged in the last few years allowing effective percutaneous management of complex coronary disease. In this review we examine the evidence base underpinning multivessel percutaneous coronary intervention across the spectrum of stable and acute coronary syndromes.

摘要

冠心病在全球范围内具有显著的发病率和死亡率。肥胖症和糖尿病的流行以及人口老龄化导致了相当一部分多支血管病变的患者,这给治疗带来了重大挑战。近年来,冠状动脉介入治疗领域出现了许多进展,使得复杂冠状动脉疾病的经皮治疗更加有效。在这篇综述中,我们考察了稳定型和急性冠状动脉综合征多支血管经皮冠状动脉介入治疗的证据基础。

相似文献

1
Percutaneous Coronary Intervention in Multi-Vessel Disease.多血管病变的经皮冠状动脉介入治疗。
Cardiovasc Revasc Med. 2022 Nov;44:80-91. doi: 10.1016/j.carrev.2022.06.254. Epub 2022 Jun 24.
2
Predictors and Outcomes of Staged Versus One-Time Multivessel Revascularization in Multivessel Coronary Artery Disease: Insights From the VA CART Program.多支冠状动脉疾病中分期与一次性多血管血运重建的预测因素和结果:来自 VA CART 项目的见解。
JACC Cardiovasc Interv. 2018 Nov 26;11(22):2265-2273. doi: 10.1016/j.jcin.2018.07.055.
3
Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.在多支冠状动脉疾病的ST段抬高型心肌梗死患者中,非梗死相关动脉严重病变管理中血管造影引导下多支血管经皮冠状动脉介入治疗与缺血引导下经皮冠状动脉介入治疗及药物治疗的比较
Crit Pathw Cardiol. 2018 Jun;17(2):77-82. doi: 10.1097/HPC.0000000000000144.
4
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).伴有非ST段抬高型心肌梗死的糖尿病合并多支冠状动脉疾病患者的血运重建趋势:来自国家心血管数据注册库急性冠状动脉治疗和干预结果网络注册库-遵循指南行动(NCDR ACTION注册库-GWTG)的见解
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):197-205. doi: 10.1161/CIRCOUTCOMES.115.002084. Epub 2016 May 10.
5
Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial.糖尿病患者急性冠脉综合征的管理:FREEDOM 试验的启示。
Clin Ther. 2013 Aug;35(8):1069-75. doi: 10.1016/j.clinthera.2013.07.427.
6
Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease.罪犯血管与多血管与住院分期介入治疗 ST 段抬高型心肌梗死和多血管病变患者:高危患者群体和非罪犯病变的解剖亚组的分层分析。
JACC Cardiovasc Interv. 2017 Jan 9;10(1):11-23. doi: 10.1016/j.jcin.2016.10.024.
7
Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.多支血管病变与 ST 段抬高型心肌梗死和多支冠状动脉疾病罪犯血管血运重建的比较:随机试验的荟萃分析。
JACC Cardiovasc Interv. 2020 Jul 13;13(13):1571-1582. doi: 10.1016/j.jcin.2020.04.055.
8
Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials.经皮冠状动脉介入治疗多支冠状动脉疾病患者的完全血运重建或罪犯血管血运重建:随机试验的成对和网络荟萃分析。
JACC Cardiovasc Interv. 2017 Feb 27;10(4):315-324. doi: 10.1016/j.jcin.2016.11.047.
9
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较:外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
10
Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.经皮冠状动脉介入治疗对稳定型和不稳定型冠状动脉疾病分层的死亡和心肌梗死的影响:一项随机对照试验的荟萃分析
Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e006363. doi: 10.1161/CIRCOUTCOMES.119.006363. Epub 2020 Feb 17.

引用本文的文献

1
Predictive Scoring Model for In-Stent Restenosis Risk in Coronary Artery Disease Patients.冠心病患者支架内再狭窄风险的预测评分模型
Med Sci Monit. 2025 Jun 11;31:e947986. doi: 10.12659/MSM.947986.
2
A Systematic Review of risk factors for major adverse cardiovascular events in patients with coronary heart disease who underwent percutaneous coronary intervention.经皮冠状动脉介入治疗的冠心病患者主要不良心血管事件危险因素的系统评价
Front Physiol. 2025 Apr 9;16:1514585. doi: 10.3389/fphys.2025.1514585. eCollection 2025.
3
Paclitaxel-coated balloon catheter versus paclitaxel-eluting stent for the treatment of coronary in-stent restenosis: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials.
紫杉醇涂层球囊导管与紫杉醇洗脱支架治疗冠状动脉支架内再狭窄的比较:一项GRADE评估的随机对照试验系统评价和荟萃分析
Medicine (Baltimore). 2025 Apr 11;104(15):e42113. doi: 10.1097/MD.0000000000042113.
4
Psychological consistency network characteristics and influencing factors in patients after percutaneous coronary intervention treatment.经皮冠状动脉介入治疗术后患者的心理一致性网络特征及影响因素
World J Psychiatry. 2025 Mar 19;15(3):102571. doi: 10.5498/wjp.v15.i3.102571.
5
The association of troponin I with the incidence of atrial fibrillation (AF) after coronary artery bypass graft surgery (CABG): A prospective cohort.肌钙蛋白I与冠状动脉旁路移植术(CABG)后房颤(AF)发生率的关联:一项前瞻性队列研究。
JRSM Cardiovasc Dis. 2025 Mar 16;14:20480040251326241. doi: 10.1177/20480040251326241. eCollection 2025 Jan-Dec.
6
Effects of multiple protection model in the operating room on physiological stress and risk events in patients undergoing coronary artery stent implantation.手术室多重保护模式对行冠状动脉支架植入术患者生理应激及风险事件的影响。
Biomed Eng Online. 2024 Aug 28;23(1):86. doi: 10.1186/s12938-024-01283-3.
7
Outcomes of myocardial revascularization in patients with obesity and multivessel coronary artery disease.肥胖合并多支冠状动脉疾病患者心肌血运重建的结果
Egypt Heart J. 2024 Aug 28;76(1):114. doi: 10.1186/s43044-024-00548-5.
8
Intermediate-Term Prognostic Value of Homocysteine in Acute Coronary Syndrome Complicated with or without Hypertension: A Multicenter Observational Cohort Study.同型半胱氨酸在伴或不伴高血压的急性冠脉综合征中的中期预后价值:一项多中心观察性队列研究
Rev Cardiovasc Med. 2023 Jul 18;24(7):210. doi: 10.31083/j.rcm2407210. eCollection 2023 Jul.
9
Comparative Efficacy of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in the Treatment of Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Recent Randomized Controlled Trials.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗缺血性心脏病的疗效比较:近期随机对照试验的系统评价和荟萃分析
Cardiol Res. 2024 Jun;15(3):153-168. doi: 10.14740/cr1638. Epub 2024 Jun 25.
10
Percutaneous Coronary Intervention as a Non-Surgical Treatment for Ischemic Mitral Regurgitation in Patients with Multi-Vessel Coronary Artery Disease.经皮冠状动脉介入治疗作为多支冠状动脉疾病患者缺血性二尖瓣反流的非手术治疗方法。
Med Sci Monit. 2024 May 27;30:e943122. doi: 10.12659/MSM.943122.